{
    "name": "Schedule III",
    "number": "18",
    "text": "\u00a7329-18\u00a0 Schedule III.\u00a0 (a)\u00a0 The controlled substances listed in this section are included in schedule III.\n\u00a0\u00a0\u00a0\u00a0 (b)\u00a0 Stimulants.\u00a0 Unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including their salts, isomers, and salts of isomers, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation:\n\u00a0\u00a0\u00a0\u00a0 (1)\u00a0 Those compounds, mixtures, or preparations in dosage unit form containing any stimulant substance listed in schedule II, and any other drug of the quantitative composition or which is the same except that it contains a lesser quantity of controlled substances;\n\u00a0\u00a0\u00a0\u00a0 (2)\u00a0 Benzphetamine;\n\u00a0\u00a0\u00a0\u00a0 (3)\u00a0 Chlorphentermine;\n\u00a0\u00a0\u00a0\u00a0 (4)\u00a0 Clortermine;\n\u00a0\u00a0\u00a0\u00a0 (5)\u00a0 Mazindol;\n\u00a0\u00a0\u00a0\u00a0 (6)\u00a0 Phendimetrazine.\n\u00a0\u00a0\u00a0\u00a0 (c)\u00a0 Depressants.\u00a0 Unless listed in another schedule, any material, compound, mixture, or preparation containing any quantity of the following substances having a depressant effect on the central nervous system:\n\u00a0\u00a0\u00a0\u00a0 (1)\u00a0 Any compound, mixture, or preparation containing amobarbital, secobarbital, pentobarbital, or any salt thereof and one or more other active medicinal ingredients which are not listed in any schedule;\n\u00a0\u00a0\u00a0\u00a0 (2)\u00a0 Any suppository dosage form containing amobarbital, secobarbital, pentobarbital, or any salt of any of these drugs and approved by the Food and Drug Administration for marketing only as a suppository;\n\u00a0\u00a0\u00a0\u00a0 (3)\u00a0 Any substance that contains any quantity of a derivative of barbituric acid or any salt thereof, including the substance butalbital;\n\u00a0\u00a0\u00a0\u00a0 (4)\u00a0 Chlorhexadol;\n\u00a0\u00a0\u00a0\u00a0 (5)\u00a0 Embutramide (Tributame);\n\u00a0\u00a0\u00a0\u00a0 (6)\u00a0 Ketamine, its salts, isomers, and salts of isomers, also known as (+ or -)-2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone;\n\u00a0\u00a0\u00a0\u00a0 (7)\u00a0 Lysergic acid;\n\u00a0\u00a0\u00a0\u00a0 (8)\u00a0 Lysergic acid amide;\n\u00a0\u00a0\u00a0\u00a0 (9)\u00a0 Methyprylon;\n\u00a0\u00a0\u00a0 (10)\u00a0 Sulfondiethylmethane;\n\u00a0\u00a0\u00a0 (11)\u00a0 Sulfonethylmethane;\n\u00a0\u00a0\u00a0 (12)\u00a0 Sulfonmethane;\n\u00a0\u00a0\u00a0 (13)\u00a0 Tiletamine/Zolazepam (Telazol, 2-(ethylamino)-2-(-thienyl)-cyclohexanone, flupyrazapon) or any salts thereof;\n\u00a0\u00a0\u00a0 (14)\u00a0 Gamma hydroxybutyric acid and its salts, isomers, and salts of isomers that are contained in a drug product for which an application has been approved under section 505 of the federal Food, Drug, and Cosmetic Act;\n\u00a0\u00a0\u00a0 (15)\u00a0 Perampanel [2-(2-oxo-1-phenyl-5-pyridin-2-yl-l,2-dihydropyridin-3-yl)benzonitrile], including its salts, isomers, and salts of isomers; and\n\u00a0\u00a0\u00a0 (16)\u00a0 Alfaxalone 5[alpha]-pregnan-3[alpha]-ol-11,20-dione, including its salts, isomers, and salts of isomers.\n\u00a0\u00a0\u00a0\u00a0 (d)\u00a0 Nalorphine.\n\u00a0\u00a0\u00a0\u00a0 (e)\u00a0 Narcotic drugs.\u00a0 Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any of the following narcotic drugs, or their salts, or alkaloid, in limited quantities as set forth below:\n\u00a0\u00a0\u00a0\u00a0 (1)\u00a0 Not more than 1.8 grams of codeine, or any of its salts, per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium;\n\u00a0\u00a0\u00a0\u00a0 (2)\u00a0 Not more than 1.8 grams of codeine, or any of its salts, per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts;\n\u00a0\u00a0\u00a0\u00a0 (3)\u00a0 Not more than 1.8 grams of dihydrocodeine, or any of its salts, per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts;\n\u00a0\u00a0\u00a0\u00a0 (4)\u00a0 Not more than 300 milligrams of ethylmorphine, or any of its salts, per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more ingredients in recognized therapeutic amounts;\n\u00a0\u00a0\u00a0\u00a0 (5)\u00a0 Not more than 500 milligrams of opium per 100 milliliters or per 100 grams, or not more than 25 milligrams per dosage unit, with one or more active nonnarcotic ingredients in recognized therapeutic amounts;\n\u00a0\u00a0\u00a0\u00a0 (6)\u00a0 Not more than 50 milligrams of morphine or any of its salts, per 100 milliliters or per 100 grams with one or more active, nonnarcotic ingredients in recognized therapeutic amounts; and\n\u00a0\u00a0\u00a0\u00a0 (7)\u00a0 Buprenorphine.\n\u00a0\u00a0\u00a0\u00a0 (f)\u00a0 The department of public safety may except by rule any compound, mixture, or preparation containing any stimulant or depressant substance listed in subsections (b) and (c) from the application of all or any part of this chapter if the compound, mixture, or preparation contains one or more active medicinal ingredients not having a stimulant or depressant effect on the central nervous system, and if the admixtures are included therein in combinations, quantity, proportion, or concentration that vitiate the potential for abuse of the substances which have a stimulant or depressant effect on the central nervous system.\n\u00a0\u00a0\u00a0\u00a0 (g)\u00a0 Any anabolic steroid.\u00a0 The term \"anabolic steroid\" means any drug or hormonal substance chemically and pharmacologically related to testosterone (other than estrogens, progestins, and corticosteroids) that promotes muscle growth, and includes:\n\u00a0\u00a0\u00a0\u00a0 (1)\u00a0 Boldenone;\n\u00a0\u00a0\u00a0\u00a0 (2)\u00a0 Clostebol (4\u2011Chlorotestosterone);\n\u00a0\u00a0\u00a0\u00a0 (3) Dehydrochlormethyltestosterone;\n\u00a0\u00a0\u00a0\u00a0 (4)\u00a0 Dihydrotestosterone (4\u2011dihydrotestosterone);\n\u00a0\u00a0\u00a0\u00a0 (5)\u00a0 Drostanolone;\n\u00a0\u00a0\u00a0\u00a0 (6)\u00a0 Ethylestrenol;\n\u00a0\u00a0\u00a0\u00a0 (7)\u00a0 Fluoxymesterone;\n\u00a0\u00a0\u00a0\u00a0 (8)\u00a0 Formebolone (Formyldienolone);\n\u00a0\u00a0\u00a0\u00a0 (9)\u00a0 Mesterolone;\n\u00a0\u00a0\u00a0 (10)\u00a0 Methandranone;\n\u00a0\u00a0\u00a0 (11)\u00a0 Methandriol;\n\u00a0\u00a0\u00a0 (12)\u00a0 Methandrostenolone (Methandienone);\n\u00a0\u00a0\u00a0 (13)\u00a0 Methenolone;\n\u00a0\u00a0\u00a0 (14)\u00a0 Methyltestosterone;\n\u00a0\u00a0\u00a0 (15)\u00a0 Mibolerone;\n\u00a0\u00a0\u00a0 (16)\u00a0 Nandrolone;\n\u00a0\u00a0\u00a0 (17)\u00a0 Norethandrolone;\n\u00a0\u00a0\u00a0 (18)\u00a0 Oxandrolone;\n\u00a0\u00a0\u00a0 (19)\u00a0 Oxymesterone;\n\u00a0\u00a0\u00a0 (20)\u00a0 Oxymetholone;\n\u00a0\u00a0\u00a0 (21)\u00a0 Stanolone (Dihydrotestosterone);\n\u00a0\u00a0\u00a0 (22)\u00a0 Stanozolol;\n\u00a0\u00a0\u00a0 (23)\u00a0 Testolactone;\n\u00a0\u00a0\u00a0 (24)\u00a0 Testosterone;\n\u00a0\u00a0\u00a0 (25)\u00a0 Trenbolone;\n\u00a0\u00a0\u00a0 (26)\u00a0 3[beta], 17-dihydroxy-5a-androstane;\n\u00a0\u00a0\u00a0 (27)\u00a0 3[alpha], 17[beta]-dihydroxy-5a-androstane;\n\u00a0\u00a0\u00a0 (28)\u00a0 5[alpha]-androstan-3, 17-dione;\n\u00a0\u00a0\u00a0 (29)\u00a0 1-androstenediol (3[beta], 17[beta]-dihydroxy-5[alpha]-androst-1-ene);\n\u00a0\u00a0\u00a0 (30)\u00a0 1-androstenediol (3[alpha], 17[beta]-dihydroxy-5[alpha]-androst-1-ene);\n\u00a0\u00a0\u00a0 (31)\u00a0 4-androstenediol (3[beta], 17[beta]-dihydroxy-androst-4-ene);\n\u00a0\u00a0\u00a0 (32)\u00a0 5-androstenediol (3[beta], 17[beta]-dihydroxy-androst-5-ene);\n\u00a0\u00a0\u00a0 (33)\u00a0 1-androstenedione ([5[alpha]]-androst-1-en-3, 17\u2011dione);\n\u00a0\u00a0\u00a0 (34)\u00a0 4-androstenedione (androst-4-en-3, 17-dione);\n\u00a0\u00a0\u00a0 (35)\u00a0 5-androstenedione (androst-5-en-3, 17-dione);\n\u00a0\u00a0\u00a0 (36)\u00a0 Bolasterone (7[alpha], 17[alpha]-dimethyl-17[beta]-hydroxyandrost-4-en-3-one);\n\u00a0\u00a0\u00a0 (37)\u00a0 Calusterone (7[beta], 17[alpha]-dimethyl-17[beta]-hydroxyandrost-4-en-3-one);\n\u00a0\u00a0\u00a0 (38)\u00a0 [Delta]1-dihydrotestosterone (a.k.a. '1-testosterone') (17[beta]-hydroxy-5[alpha]-androst-1-en-3-one);\n\u00a0\u00a0\u00a0 (39)\u00a0 Furazabol (17[alpha]-methyl-17[beta]-hydroxyandrostano[2,3-c]-furazan);\n\u00a0\u00a0\u00a0 (40)\u00a0 13[beta]-ethyl-17[beta]-hydroxygon-4-en-3-one;\n\u00a0\u00a0\u00a0 (41)\u00a0 4-hydroxytestosterone (4,17[beta]-dihydroxy-androst-4\u2011en-3-one);\n\u00a0\u00a0\u00a0 (42)\u00a0 4-hydroxy-19-nortestosterone (4,17[beta]-dihydroxy-estr-4-en-3-one);\n\u00a0\u00a0\u00a0 (43)\u00a0 Mesterolone (1[alpha]methyl-17[beta]-hydroxy-[5[alpha]]-androstan-3-one);\n\u00a0\u00a0\u00a0 (44)\u00a0 Methandienone (17[alpha]-methyl-17[beta]-hydroxyandrost-1,4-dien-3-one);\n\u00a0\u00a0\u00a0 (45)\u00a0 Methandriol (17[alpha]-methyl-3[beta], 17[beta]-dihydroxyandrost-5-ene);\n\u00a0\u00a0\u00a0 (46)\u00a0 Methenolone (1-methyl-17[beta]-hydroxy-5[alpha]-androst-1-en-3-one);\n\u00a0\u00a0\u00a0 (47)\u00a0 17[alpha]-methyl-3[beta], 17[beta]-dihydroxy-5a\u2011androstane;\n\u00a0\u00a0\u00a0 (48)\u00a0 17[alpha]-methyl-3[alpha], 17[beta]-dihydroxy-5a\u2011androstane;\n\u00a0\u00a0\u00a0 (49)\u00a0 17[alpha]-methyl-3[beta], 17[beta]-dihydroxyandrost-4\u2011ene;\n\u00a0\u00a0\u00a0 (50)\u00a0 17[alpha]-methyl-4-hydroxynandrolone (17[alpha]-methyl-4-hydroxy-17[beta]-hydroxyestr-4-en-3-one);\n\u00a0\u00a0\u00a0 (51)\u00a0 Methyldienolone (17[alpha]-methyl-17[beta]-hydroxyestra-4, 9(10)-dien-3-one);\n\u00a0\u00a0\u00a0 (52)\u00a0 Methyltrienolone (17[alpha]-methyl-17[beta]-hydroxyestra-4, 9-11-trien-3-one);\n\u00a0\u00a0\u00a0 (53)\u00a0 17[alpha]-methyl-[Delta] 1-dihydrotestosterone (17b [beta]-hydroxy-17[alpha]-methyl-5[alpha]-androst-1-en-3-one) (a.k.a. '17-[alpha]-methyl-1-testosterone');\n\u00a0\u00a0\u00a0 (54)\u00a0 19-nor-4-androstenediol (3[beta], 17[beta]-dihydroxyestr-4-ene);\n\u00a0\u00a0\u00a0 (55)\u00a0 19-nor-4-androstenediol (3[alpha], 17[beta]-dihydroxyestr-4-ene);\n\u00a0\u00a0\u00a0 (56)\u00a0 19-nor-5-androstenediol (3[beta], 17[beta]-dihydroxyestr-5-ene);\n\u00a0\u00a0\u00a0 (57)\u00a0 19-nor-5-androstenediol (3[alpha], 17[beta]-dihydroxyestr-5-ene);\n\u00a0\u00a0\u00a0 (58)\u00a0 19-nor-4-androstenedione (estr-4-en-3, 17-dione);\n\u00a0\u00a0\u00a0 (59)\u00a0 19-nor-5-androstenedione (estr-5-en-3, 17-dione);\n\u00a0\u00a0\u00a0 (60)\u00a0 Norbolethone (13[beta], 17[alpha]-diethyl-17[beta]-hydroxygon-4-en-3-one);\n\u00a0\u00a0\u00a0 (61)\u00a0 Norclostebol (4-chloro-17[beta]-hydroxyestr-4-en-3\u2011one);\n\u00a0\u00a0\u00a0 (62)\u00a0 Normethandrolone (17[alpha]-methyl-17[beta]-hydroxyestr-4-en-3-one);\n\u00a0\u00a0\u00a0 (63)\u00a0 Stenbolone (17[beta]-hydroxy-2-methyl-[5[alpha]]-androst-1-en-3-one);\n\u00a0\u00a0\u00a0 (64)\u00a0 Tetrahydrogestrinone (13[beta], 17[alpha]-diethyl-17[beta]-hydroxygon-4, 9, 11-trien-3-one);\n\u00a0\u00a0\u00a0 (65)\u00a0 Desoxymethyltestosterone (17a-methyl-5a-androst-2-en-17-ol, madol);\n\u00a0\u00a0\u00a0 (66)\u00a0 19-nor-4,9(10)-androstadienedione (estra-4,9(10)-diene-3,17-dione);\n\u00a0\u00a0\u00a0 (67)\u00a0 Boldione (Androsta-1,4-diene-3,17-dione); \n\u00a0\u00a0\u00a0 (68)\u00a0 Methasterone (2 alpha-17 alpha-dimethyl-5 alpha-androstan-17beta-ol-3-one);\n\u00a0\u00a0\u00a0 (69)\u00a0 Prostanozol (17 beta-hydroxy-5 alpha-androstano[3,2-c]pryazole; and\n\u00a0\u00a0\u00a0 (70)\u00a0 Any salt, ester, or isomer of a drug or substance described or listed in this subsection, if that salt, ester, or isomer promotes muscle growth, except the term \"anabolic steroid\" does not include an anabolic steroid that is expressly intended for administration through implants to cattle or other nonhuman species and that has been approved by the Secretary of Health and Human Services for nonhuman administration.\u00a0 If any person prescribes, dispenses, or distributes an anabolic steroid intended for administration to nonhuman species for human use, the person shall be considered to have prescribed, dispensed, or distributed an anabolic steroid within the meaning of this paragraph.\n\u00a0\u00a0\u00a0\u00a0 (h)\u00a0 Hallucinogenic substances, unless listed in another schedule, shall include Dronabinol (synthetic), in sesame oil and encapsulated in a soft gelatin capsule in a United States Food and Drug Administration approved drug product. [L 1972, c 10, pt of \u00a71 and am c 114, \u00a72(1); am L 1974, c 217, \u00a73; am L 1975, c 26, \u00a72; am L 1977, c 116, \u00a72; am L 1978, c 68, \u00a74; am L 1988, c 59, \u00a73; am L 1990, c 281, \u00a710; am L 1991, c 159, \u00a78; am L 1992, c 151, \u00a71; am L 1995, c 122, \u00a73; am L 1997, c 356, \u00a7\u00a73, 4; am L 2000, c 98, \u00a74; am L 2001, c 203, \u00a74; am L 2003, c 151, \u00a74; am L 2004, c 193, \u00a72; am L 2008, c 186, \u00a73; am L 2009, c 117, \u00a73; am L 2011, c 73, \u00a73; am L 2013, c 48, \u00a73; am L 2014, c 54, \u00a72; am L 2015, c 195, \u00a72]"
}